GENEART Again Honored with "BAVARIA'S BEST 50" Award>
GENEART Again Honored with "BAVARIA'S BEST 50" Award
(Thomson Reuters ONE) - Corporate news announcement processed and transmitted by Hugin AS.The issuer is solely responsible for the content of this announcement. ------------------------------------------------------------------------------------ * GENEART is among the 50 most dynamic companies in Bavaria * GENEART was awarded "BAVARIA'S BEST 50" by the Bavarian State Ministry for the third time * The Group's net sales increased by an average of 58 % over the past four yearsRegensburg, July 2, 2009 - GENEART AG is among the 50 most dynamiccompanies in Bavaria and has been awarded "BAVARIA'S BEST 50" by theBavarian State Ministry for the third time. Since its market entry in2000, GENEART evolved to the world market leader in synthetic geneproduction. Furthermore, GENEART today is one of the leading expertsworldwide in the area of Synthetic Biology.Driven by demand, GENEART has almost doubled its capacities each yearsince its foundation by continuous process improvements and anincreasing level of automation. The number of employees has increasedduring this corporate development to approximately 190.A steady expansion of the application of gene synthesis in industryand research, also in the field of Synthetic Biology, allowed GENEARTto increase its net sales on average by 58 % per annum over the lastfour years. The Group's net sales have grown from EUR 2.5M in 2004 toEUR 15.7M last year. GENEART expects its net sales for 2009 to reachat least previous year's level despite a difficult economicenvironment.The Bavarian State Minister for Economy, Infrastructure, Transportand Technology, Martin Zeil, honored the 50 most dynamic companies inMunich last night. The prize has been awarded for the eighth time tocompanies with particularly strong growth over the past years asindicated by increasing both net sales and number of employees bymore than average."We will continue to strengthen our technology leadership in thefields of Gene Synthesis and Synthetic Biology through ourinvestments in automation and miniaturization, and will furtherincrease our successful advancement as market leader. GENEART has agood basic position to profit more than average from an improvementof the market situation", said Daniel Seibert, CFO of GENEART AG.For further inquiries, please contact:Dr. Karoline StürmerGENEART AGJosef-Engert-Str. 1193053 RegensburgPhone: +49-(0)941-942 76-417Fax: +49-(0)941-942 76-711ir(at)geneart.comwww.geneart.comFrank OstermairBetter Orange IR & HV AGHaidelweg 4881241 MunichPhone: +49-(0)89-8896906-10Fax: +49-(0)89-8896906-66info(at)better-orange.dewww.better-orange.deLegal InformationThis document may contain estimates, prognoses and opinions aboutcompany plans and objectives, products or services, future results,opinions about these results or opinions leading up to these results.All these projections into the future are subject to risk,uncertainty and unforeseeable change outside the control of theGENEART AG. Many factors may lead to actual results, whichconsiderably deviate from the given projections for these results.About GENEART AG:In 2000, GENEART entered the gene synthesis market and has sincebecome the global market leader, and today, the company is one of theleading specialists in the Synthetic Biology field. Experts atGENEART provide key technologies for the development and productionof new therapeutics and vaccines. Customers also take advantage ofGENEART services to customize enzyme attributes, such as theattributes of enzymes used as detergent additives, and to constructbacteria, which produce complex biopolymers or break down polymers,such as synthetics, petroleum components, etc. Our production andservice spectrum spans a wide range, from the production of syntheticgenes according to DIN EN ISO 9001:2000, to the creation of genelibraries in the combinatorial biology, to the development andproduction of DNA-based biologically active substances. GENEART AG inRegensburg and its subsidiaries GENEART Inc. in Toronto (Canada) andGENEART Inc. in San Francisco (USA) employ more than 190 people. Thecompany is listed on the German Stock Exchange since May 2006.About BAVARIA's BEST 50:The honor BAVARIA'S BEST 50 was awarded for the eighth time on July1, 2009. The Bavarian State Minister Martin Zeil honored Bavaria's 50most dynamic companies, which showed particularly strong growth overthe past years and which increased their net sales and number ofemployees by more than average, in the Kaisersaal of the MunichResidence. This award is meant to lead the way and at the same timeencourage entrepreneurs and small and middle-sized companies inBavaria. In 2009, the auditing company Ernst & Young AG determinedBAVARIA'S BEST 50 based on the Birch Index, which main criteria aregrowth of net sales and number employees. Additional informationunder www.bb50.dehttp://hugin.info/136633/R/1326874/312449.pdf --- End of Message ---Geneart AGJosef-Engert-Str.11 Regensburg GermanyWKN: A0JJ4L; ISIN: DE000A0JJ4L4; Listed: Freiverkehr in Börse Düsseldorf, Freiverkehr in Börse Berlin, Open Market in Frankfurter Wertpapierbörse, Freiverkehr in Börse Stuttgart;
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
" alt="Teleconference invitation for press and analysts>
">Datum: 02.07.2009 - 09:15 Uhr
Sprache: Deutsch
News-ID 1002222
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
London
Phone:
Kategorie:
Business News
Anmerkungen:
Diese Pressemitteilung wurde bisher 122 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"GENEART Again Honored with "BAVARIA'S BEST 50" Award>
"
steht unter der journalistisch-redaktionellen Verantwortung von
Geneart AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
